These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 7537903

  • 1. Palliative therapy: extensive small cell lung cancer.
    Loehrer PJ.
    Semin Oncol; 1995 Apr; 22(2 Suppl 3):40-4. PubMed ID: 7537903
    [Abstract] [Full Text] [Related]

  • 2. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
    Ettinger DS.
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
    [Abstract] [Full Text] [Related]

  • 3. The role of ifosfamide in small cell lung cancer.
    Loehrer PJ.
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):40-4. PubMed ID: 8711501
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of lung cancer--state of the art in 2000].
    Nakanishi Y, Inoue K, Hara N.
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023
    [Abstract] [Full Text] [Related]

  • 5. Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
    Sandler AB.
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):38-41. PubMed ID: 9535210
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC, McCrystal MR, Christmas TI.
    N Z Med J; 1998 Nov 27; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [Abstract] [Full Text] [Related]

  • 7. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May 27; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 8. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial.
    Gatzemeier U, Pawel JV, Laumen R, Hossfeld DK, Neuhauss R.
    Semin Oncol; 1994 Jun 27; 21(3 Suppl 6):31-5. PubMed ID: 8052871
    [Abstract] [Full Text] [Related]

  • 9. Hoosier Oncology Group studies in extensive and recurrent small cell lung cancer.
    Einhorn LH, Loehrer PJ.
    Semin Oncol; 1995 Feb 27; 22(1 Suppl 2):28-31. PubMed ID: 7846539
    [Abstract] [Full Text] [Related]

  • 10. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
    Reck M, von Pawel J, Macha HN, Kaukel E, Deppermann KM, Bonnet R, Ulm K, Hessler S, Gatzemeier U.
    Lung Cancer; 2006 Jul 27; 53(1):67-75. PubMed ID: 16713013
    [Abstract] [Full Text] [Related]

  • 11. [Drug therapy in bronchial carcinoma].
    Manegold C, Drings P.
    Schweiz Med Wochenschr; 1995 Jul 22; 125(29):1396-405. PubMed ID: 7545824
    [Abstract] [Full Text] [Related]

  • 12. Ifosfamide, doxorubicin, vincristine, and etoposide in small cell lung cancer.
    Elisson LO, Ekberg L.
    Semin Oncol; 1995 Feb 22; 22(1 Suppl 2):15-7. PubMed ID: 7846536
    [Abstract] [Full Text] [Related]

  • 13. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
    Bex A, Nieuwenhuijzen JA, Kerst M, Pos F, van Boven H, Meinhardt W, Horenblas S.
    Urology; 2005 Feb 22; 65(2):295-9. PubMed ID: 15708041
    [Abstract] [Full Text] [Related]

  • 14. Ifosfamide in the treatment of small cell lung cancer.
    Ettinger DS.
    Semin Oncol; 1996 Jun 22; 23(3 Suppl 6):2-6. PubMed ID: 8677443
    [Abstract] [Full Text] [Related]

  • 15. The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma: A randomized study of 457 patients. "Petites Cellules" Group.
    Urban T, Chastang C, Lebas FX, Duhamel JP, Adam G, Darse J, Bréchot JM, Lebeau B.
    Cancer; 1999 Dec 01; 86(11):2238-45. PubMed ID: 10590363
    [Abstract] [Full Text] [Related]

  • 16. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA.
    Semin Oncol; 1994 Jun 01; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of curative and palliative radiotherapy efficacy in extensive stage small cell lung cancer.
    Diniz G, Unlu I, Gokce T, Kilciksiz S, Gayaf M, Komurcuoglu B, Karadogan I, Aktas S, Akcay C.
    Saudi Med J; 2006 Jul 01; 27(7):992-6. PubMed ID: 16830017
    [Abstract] [Full Text] [Related]

  • 18. Lung cancer.
    Hansen HH, Rørth M.
    Cancer Chemother Biol Response Modif; 1997 Jul 01; 17():444-63. PubMed ID: 9551225
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
    Ueoka H, Kiura K, Tabata M, Kamei H, Gemba K, Sakae K, Hiraki Y, Hiraki S, Segawa Y, Harada M.
    Cancer; 1998 Jul 15; 83(2):283-90. PubMed ID: 9669811
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD, Morrissey LH, Scullin DC, Houston GA, Prasthofer EF, Gray JR, Burris HA, Greco FA.
    Cancer; 2002 May 01; 94(9):2426-33. PubMed ID: 12033195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.